78 related articles for article (PubMed ID: 27976371)
1. Apolipoprotein C-I plays a role in the pathogenesis of glomerulosclerosis.
Bus P; Pierneef L; Bor R; Wolterbeek R; van Es LA; Rensen PC; de Heer E; Havekes LM; Bruijn JA; Berbée JF; Baelde HJ
J Pathol; 2017 Apr; 241(5):589-599. PubMed ID: 27976371
[TBL] [Abstract][Full Text] [Related]
2. Adjusting the 17β-Estradiol-to-Androgen Ratio Ameliorates Diabetic Nephropathy.
Inada A; Inada O; Fujii NL; Nagafuchi S; Katsuta H; Yasunami Y; Matsubara T; Arai H; Fukatsu A; Nabeshima YI
J Am Soc Nephrol; 2016 Oct; 27(10):3035-3050. PubMed ID: 26940099
[TBL] [Abstract][Full Text] [Related]
3. Targeting Macrophages: Therapeutic Approaches in Diabetic Kidney Disease.
Lin DW; Yang TM; Ho C; Shih YH; Lin CL; Hsu YC
Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673935
[TBL] [Abstract][Full Text] [Related]
4. Editorial: Mechanism and therapeutic potential of macrophages in metabolic and cardiovascular diseases.
Nie X; Deng Y; Tong X; Han F
Front Immunol; 2023; 14():1352567. PubMed ID: 38173724
[No Abstract] [Full Text] [Related]
5. APOC1 exacerbates renal fibrosis through the activation of the NF-κB signaling pathway in IgAN.
Yu K; Ding L; An X; Yang Y; Zhang X; Li L; Wang C; Bai F; Yang X
Front Pharmacol; 2023; 14():1181435. PubMed ID: 37305534
[No Abstract] [Full Text] [Related]
6. APOC1 as a novel diagnostic biomarker for DN based on machine learning algorithms and experiment.
Yu K; Li S; Wang C; Zhang Y; Li L; Fan X; Fang L; Li H; Yang H; Sun J; Yang X
Front Endocrinol (Lausanne); 2023; 14():1102634. PubMed ID: 36891052
[TBL] [Abstract][Full Text] [Related]
7. Systematic pan-cancer analysis identifies APOC1 as an immunological biomarker which regulates macrophage polarization and promotes tumor metastasis.
Ren L; Yi J; Yang Y; Li W; Zheng X; Liu J; Li S; Yang H; Zhang Y; Ge B; Zhang S; Fu W; Dong D; Du G; Wang X; Wang J
Pharmacol Res; 2022 Sep; 183():106376. PubMed ID: 35914680
[TBL] [Abstract][Full Text] [Related]
8. Role of apolipoprotein C1 in lipoprotein metabolism, atherosclerosis and diabetes: a systematic review.
Rouland A; Masson D; Lagrost L; Vergès B; Gautier T; Bouillet B
Cardiovasc Diabetol; 2022 Dec; 21(1):272. PubMed ID: 36471375
[TBL] [Abstract][Full Text] [Related]
9. Hydroxychloroquine alleviates renal interstitial fibrosis by inhibiting the PI3K/Akt signaling pathway.
Li D; Yu K; Feng F; Zhang Y; Bai F; Zhang Y; Sun N; Fan J; Liu L; Yang H; Yang X
Biochem Biophys Res Commun; 2022 Jun; 610():154-161. PubMed ID: 35462097
[TBL] [Abstract][Full Text] [Related]
10. Upregulation of TIPE1 in tubular epithelial cell aggravates diabetic nephropathy by disrupting PHB2 mediated mitophagy.
Liu L; Bai F; Song H; Xiao R; Wang Y; Yang H; Ren X; Li S; Gao L; Ma C; Yang X; Liang X
Redox Biol; 2022 Apr; 50():102260. PubMed ID: 35152003
[TBL] [Abstract][Full Text] [Related]
11. The Apolipoprotein C1 is involved in breast cancer progression via EMT and MAPK/JNK pathway.
Zhang H; Wang Y; Liu C; Li W; Zhou F; Wang X; Zheng J
Pathol Res Pract; 2022 Jan; 229():153746. PubMed ID: 34952429
[TBL] [Abstract][Full Text] [Related]
12. Predictors of Kidney Disease Progression in Diabetes and Precision Medicine: Something Old, Something New, and Something Borrowed.
Vasquez-Rios G; Coca SG
J Am Soc Nephrol; 2021 Sep; 32(9):2108-2111. PubMed ID: 34465605
[No Abstract] [Full Text] [Related]
13. How will artificial intelligence and bioinformatics change our understanding of IgA Nephropathy in the next decade?
Bülow RD; Dimitrov D; Boor P; Saez-Rodriguez J
Semin Immunopathol; 2021 Oct; 43(5):739-752. PubMed ID: 33835214
[TBL] [Abstract][Full Text] [Related]
14. IDO1 as a new immune biomarker for diabetic nephropathy and its correlation with immune cell infiltration.
Yu K; Li D; Xu F; Guo H; Feng F; Ding Y; Wan X; Sun N; Zhang Y; Fan J; Liu L; Yang H; Yang X
Int Immunopharmacol; 2021 May; 94():107446. PubMed ID: 33581581
[TBL] [Abstract][Full Text] [Related]
15. Worldwide Epidemiology of Diabetes-Related End-Stage Renal Disease, 2000-2015.
Cheng HT; Xu X; Lim PS; Hung KY
Diabetes Care; 2021 Jan; 44(1):89-97. PubMed ID: 33203706
[TBL] [Abstract][Full Text] [Related]
16. Association of Multiple Plasma Biomarker Concentrations with Progression of Prevalent Diabetic Kidney Disease: Findings from the Chronic Renal Insufficiency Cohort (CRIC) Study.
Schrauben SJ; Shou H; Zhang X; Anderson AH; Bonventre JV; Chen J; Coca S; Furth SL; Greenberg JH; Gutierrez OM; Ix JH; Lash JP; Parikh CR; Rebholz CM; Sabbisetti V; Sarnak MJ; Shlipak MG; Waikar SS; Kimmel PL; Vasan RS; Feldman HI; Schelling JR;
J Am Soc Nephrol; 2021 Jan; 32(1):115-126. PubMed ID: 33122288
[TBL] [Abstract][Full Text] [Related]
17. Apolipoprotein C1 (APOC1): A Novel Diagnostic and Prognostic Biomarker for Clear Cell Renal Cell Carcinoma.
Cui Y; Miao C; Hou C; Wang Z; Liu B
Front Oncol; 2020; 10():1436. PubMed ID: 32974161
[No Abstract] [Full Text] [Related]
18. ApoC1 promotes the metastasis of clear cell renal cell carcinoma via activation of STAT3.
Li YL; Wu LW; Zeng LH; Zhang ZY; Wang W; Zhang C; Lin NM
Oncogene; 2020 Sep; 39(39):6203-6217. PubMed ID: 32826950
[TBL] [Abstract][Full Text] [Related]
19. Tim-3 aggravates podocyte injury in diabetic nephropathy by promoting macrophage activation via the NF-κB/TNF-α pathway.
Yang H; Xie T; Li D; Du X; Wang T; Li C; Song X; Xu L; Yi F; Liang X; Gao L; Yang X; Ma C
Mol Metab; 2019 May; 23():24-36. PubMed ID: 30862474
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
